New Inspector General Finds NSF Resistant To Oversight

A conflict-of-interest case demonstrates that she lacks the power to enforce guidelines on post-employment contact WASHINGTON - Last year the National Science Foundation broke its own rule that bars former employees from discussing a potential grant or contract with foundation officials for at least one year. But when NSF's new inspector general blew the whistle on the infringement, agency officials in effect shrugged their shoulders and promised to do better the next time around. The case of

Written byJeffrey Mervis
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share


A conflict-of-interest case demonstrates that she lacks the power to enforce guidelines on post-employment contact
WASHINGTON - Last year the National Science Foundation broke its own rule that bars former employees from discussing a potential grant or contract with foundation officials for at least one year. But when NSF's new inspector general blew the whistle on the infringement, agency officials in effect shrugged their shoulders and promised to do better the next time around.

The case of Stanley Presser, a sociologist at the University of Maryland and a former program director within NSF's division of social and economic sciences, suggests that the relationship between the new office and the foundation can get a little rocky at times. The inspector general's office, created by legislation passed in 1988, is supposed to watch over the $2 billion foundation. But the investigations conducted by IG Linda Sundro and her staff into alleged financial ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies